We’re incredibly excited to share that Athelas (https://www.athelas.com) has raised $132mm+ in two consecutive rounds led by General Catalyst and Tribe Capital respectively, along with investment from Sequoia Capital, YCombinator, Greenoaks, Human Capital, and Initialized Capital. Athelas is the fastest-growing remote patient monitoring (RPM) platform in the country, and helps hospitals, health systems, and small practices deliver healthcare in the home and grow their revenue. The company is now valued at $1.5B+
Athelas is building the sensor and software infrastructure necessary to power digital healthcare. Our LTE-connected devices allow clinicians to monitor chronically ill patients in their homes, and launch clinical interventions from an EHR-adjacent software portal. Healthcare businesses use Athelas to rapidly grow revenue by launching remote-care services and improve patient outcomes.
The Athelas platform is integrated with major EHR providers, and comes supplied with clinical staff + a support team for rapid rollout across a healthcare system’s chronic population.
In the last year we’ve grown active patients on our platform by 10x. Athelas serves over 40,000 patients across thousands of healthcare providers, and is the largest provider of Remote Patient Monitoring services in the country. Our product helps health systems monitor chronic conditions such as hypertension, cardiac disorders, immunosuppression, kidney failure, weight gain, diabetes and more from the home.
We’re the only company to provide a truly end-to-end RPM program at no upfront cost to providers. Athelas pays for all devices, handles all operations of onboarding and compliance, and we even conduct full-stack medical billing, giving health systems + practices a truly turnkey solution.
Athelas is partnering closely with healthcare providers, hospitals, health systems, and digital health companies to supercharge their in-home care delivery efforts. With our software tools, cutting-edge FDA-cleared medical devices, and team of clinical staff, healthcare systems are able to launch remote care programs that improve patient outcomes and drive immediate revenue.
The Athelas team builds its own targeted sensors - such as the Athelas One (FDA Cleared blood diagnostic device) and PillTrack - along with using LTE-enabled blood pressure, weight, glucose, and pulse ox monitoring for physiological metrics in the home.
If you’re in engineering, sales, business development, operations, or just want to roll up your sleeves and get to work on American healthcare, message us at firstname.lastname@example.org.
If you’re interested in partnering with Athelas, or launching a remote care program, message email@example.com.
"Athelas has been making steady progress in proving the impact that RPM can have in helping providers serve their chronic patients in their homes. Their integrated suite of software, services and devices are being used to serve tens of thousands of patients and the company is poised to be a leader in this category." said Hemant Taneja from General Catalyst – architect of GC’s Health Assurance vision – who has joined the Athelas board. Arjun Sethi of Tribe Capital has also joined as a Board Observer, alongside Alfred Lin from Sequoia Capital who serves as a Board Observer.
• Bloomberg: Health Startup Athelas Hits $1.5 Billion Valuation After Pandemic Boom
• RPM tech provider Athelas hits unicorn status with $132M raised for chronic care management